AI
CDNA icon

Atom Investors’s CareDx CDNA Stock Holding History

Atom Investors’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-160,587
Closed -$5.69M – 520
2020
Q2 		$5.69M Sell
160,587
-2,705
-2% -$77K 0.37% 51
2020
Q1 		$3.56M Buy
163,292
+9,135
+6% +$205K 0.31% 78
2019
Q4 		$3.33M Buy
+154,157
New +$3.54M 0.27% 101

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Atom Investors's CDNA Position: Q3 2020 in Review

Atom Investors sold out of CareDx (CDNA) in Q3 2020, closing a stake of 160,587 shares — an estimated $5.69M sold.

Atom Investors first reported a position in CDNA in Q4 2019 and held it in 3 quarters. The position peaked at $5.69M in Q2 2020. 197 funds tracked by Wall St. Rank hold CDNA as of Q3 2020.

  • Atom Investors reported no remaining CareDx position as of Q3 2020 after selling out during the quarter.
  • Atom Investors sold 160,587 CareDx shares in Q3 2020, an estimated $5.69M.
  • Atom Investors first reported a position in CareDx in Q4 2019 and held it in 3 quarters.
  • Atom Investors's CareDx position peaked at $5.69M in Q2 2020.
  • 197 funds tracked by Wall St. Rank held CareDx as of Q3 2020.

Based on Atom Investors's 13F filing for Q3 2020, filed 13 Nov 2020.